Home » Topics » BioWorld Science

BioWorld Science
RSS

GARNET data show potential of dostarlimab in recurrent or advanced dMMR endometrial cancer

April 24, 2020

Phase I/II study of NOX-A12 in brain cancer cleared to begin second cohort

April 24, 2020

Phase III PROfound trial of Lynparza in CRPC shows statistically significant improvement in OS

April 24, 2020

Summary trial results for CL-2020 in acute myocardial infarction and ischemic stroke

April 24, 2020

Phase IIb study of RV-001 in prostate cancer treats first patient in Germany

April 24, 2020

Phase IIa study of BIO-11006 shows reduced all-cause mortality from ARDS

April 24, 2020

In antibody ensemble, second fiddles help the neutralizing stars

April 24, 2020

NCS1 is a potential therapeutic target for Wolfram syndrome

April 24, 2020

Valneva and Dynavax collaborate on vaccine program for COVID-19

April 24, 2020

New approach generates biohybrid microswimmers with nanoerythrosome carriers

April 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...